Researchers from Newcastle University and The RVI are conducting a new study looking into giving heparin after birth as a tablet rather than by injection.
From the research team:
One of the tablet treatments is dabigatran, which has been used to prevent blood clots in non-pregnant patients. The chemical structure of dabigatran led us to suspect that it might not get into breastmilk. This will make it a more convenient and cheaper alternative to heparin injections.
We have some encouraging data from 2 non-breastfeeding mothers who took dabigatran and gave breastmilk samples over a 10 hour period for research.
We now want to extend this work by getting samples from more women over a longer period of time (24 hours). If successful, this will result in mothers being offered tablets to prevent blood clots instead of injections.
We would like to talk to a small group of expectant or new mums about these next steps of this study, to see what the challenges might be and to gather your feedback and thoughts.
They would like to discuss…
- Information on how women value tablets compared to injections
- Identifying potential barriers to women participating in the study
- Study design to make it acceptable to women
The research session will take place on:
October 28th at 1pm
It will be an informal 1-hour session. Please feel free to meet the needs of your baby during the session – feed, change and soothe as you need to.
There will be up to 4 mums and it runs over Zoom – you will be sent an invitation to join the session.
If you would like to join, please just send me a message.
And a huge thank you – your input is so valuable to research, it makes such a difference to researchers and each project.